Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

Novel nAChR ligands prepared as potential cognitive enhancers

Dec. 10, 1997

Lilly discovers highly potent and selective NPY Y1 receptor antagonists

Dec. 9, 1997

Safe and effective new D2 partial agonist in development at Wyeth-Ayerst

Dec. 9, 1997

Novel valproic acid prodrug reported at scientific meeting

Dec. 9, 1997

New antihyperalgesic agents from Adolor

Dec. 9, 1997

Pfizer improves on NMDA antagonists

Dec. 9, 1997

New muscarinic compound from Wyeth-Ayerst

Dec. 9, 1997

Egis reports safe and effective new anxiolytic

Dec. 8, 1997

New antipsychotic reported in development at Merck KGaA

Dec. 4, 1997

S-2474: antiarthritic agent with dual NSAID/DMARD profile

Dec. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...